{"id":"https://openalex.org/W2053963792","doi":"https://doi.org/10.1517/14728222.9.3.593","title":"Glucagon as a target for the treatment of Type 2 diabetes","display_name":"Glucagon as a target for the treatment of Type 2 diabetes","alternate_titles":[],"publication_year":2005,"publication_date":"2005-06-01","ids":{"openalex":"https://openalex.org/W2053963792","doi":"https://doi.org/10.1517/14728222.9.3.593","mag":"2053963792","pmid":"https://pubmed.ncbi.nlm.nih.gov/15948676"},"language":"en","primary_location":{"id":"doi:10.1517/14728222.9.3.593","doi":"https://doi.org/10.1517/14728222.9.3.593","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14728222.9.3.593","pdf_url":null,"source":{"id":"https://openalex.org/S149756942","display_name":"Expert Opinion on Therapeutic Targets","issn_l":"1472-8222","issn":["1472-8222","1744-7631"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Therapeutic Targets","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2053963792"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068951024","display_name":"Kyle W. Sloop","orcid":"https://orcid.org/0000-0001-6748-9929","observed_orcids":["https://orcid.org/0000-0001-6748-9929"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kyle W Sloop","raw_affiliation_strings":["Endocrine Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA. sloop_kyle_w@lilly.com","Eli Lilly and Company, Endocrine Discovery, Lilly Research Laboratories, Indianapolis, Indiana 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocrine Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA. sloop_kyle_w@lilly.com","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Eli Lilly and Company, Endocrine Discovery, Lilly Research Laboratories, Indianapolis, Indiana 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000633665","display_name":"M. Dodson Michael","orcid":"https://orcid.org/0000-0002-0224-1065","observed_orcids":["https://orcid.org/0000-0002-0224-1065"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Dodson Michael","raw_affiliation_strings":["Eli Lilly and Company, Endocrine Discovery, Lilly Research Laboratories, Indianapolis, Indiana 46285, USA;. sloop_kyle_w@lilly.com","Eli Lilly and Company, Endocrine Discovery, Lilly Research Laboratories, Indianapolis, Indiana 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Endocrine Discovery, Lilly Research Laboratories, Indianapolis, Indiana 46285, USA;. sloop_kyle_w@lilly.com","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Eli Lilly and Company, Endocrine Discovery, Lilly Research Laboratories, Indianapolis, Indiana 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001702290","display_name":"Julie S. Moyers","orcid":"https://orcid.org/0000-0003-1779-1390","observed_orcids":["https://orcid.org/0000-0003-1779-1390"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie S Moyers","raw_affiliation_strings":["Eli Lilly and Company, Endocrine Discovery, Lilly Research Laboratories, Indianapolis, Indiana 46285, USA;. sloop_kyle_w@lilly.com","Eli Lilly and Company, Endocrine Discovery, Lilly Research Laboratories, Indianapolis, Indiana 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Endocrine Discovery, Lilly Research Laboratories, Indianapolis, Indiana 46285, USA;. sloop_kyle_w@lilly.com","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Eli Lilly and Company, Endocrine Discovery, Lilly Research Laboratories, Indianapolis, Indiana 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":null,"apc_paid":null,"fwci":0.3827,"has_fulltext":false,"cited_by_count":65,"citation_normalized_percentile":{"value":0.39521531,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"9","issue":"3","first_page":"593","last_page":"600"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glucagon","display_name":"glucagon","score":0.9750000238418579},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9649999737739563},{"id":"https://openalex.org/keywords/glucagon-receptor-antagonists","display_name":"glucagon receptor antagonists","score":0.9570000171661377},{"id":"https://openalex.org/keywords/glucagon-receptor","display_name":"glucagon receptor","score":0.503000020980835},{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.8259999752044678},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.7419999837875366},{"id":"https://openalex.org/keywords/hepatic-glucose-production","display_name":"hepatic glucose production","score":0.8980000019073486},{"id":"https://openalex.org/keywords/counterregulatory-hormones","display_name":"counterregulatory hormones","score":0.746999979019165},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.6859999895095825}],"concepts":[{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.9079533815383911},{"id":"https://openalex.org/C2778542361","wikidata":"https://www.wikidata.org/wiki/Q14904911","display_name":"Glucagon receptor","level":4,"score":0.886142909526825},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7456427812576294},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7318356037139893},{"id":"https://openalex.org/C20904676","wikidata":"https://www.wikidata.org/wiki/Q191835","display_name":"Gluconeogenesis","level":3,"score":0.6099984645843506},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5995987057685852},{"id":"https://openalex.org/C2777499176","wikidata":"https://www.wikidata.org/wiki/Q174936","display_name":"Glycogen","level":2,"score":0.4616135358810425},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.42221567034721375},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37440621852874756},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29830312728881836},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.08711394667625427}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D005934","descriptor_name":"Glucagon","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D005934","descriptor_name":"Glucagon","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1517/14728222.9.3.593","doi":"https://doi.org/10.1517/14728222.9.3.593","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14728222.9.3.593","pdf_url":null,"source":{"id":"https://openalex.org/S149756942","display_name":"Expert Opinion on Therapeutic Targets","issn_l":"1472-8222","issn":["1472-8222","1744-7631"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Therapeutic Targets","raw_type":"journal-article"},{"id":"pmid:15948676","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15948676","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on therapeutic targets","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":58,"referenced_works":["https://openalex.org/W29427600","https://openalex.org/W38609368","https://openalex.org/W1589654194","https://openalex.org/W1946234531","https://openalex.org/W1964872621","https://openalex.org/W1969550954","https://openalex.org/W1978557997","https://openalex.org/W1985847165","https://openalex.org/W1986490291","https://openalex.org/W1988582067","https://openalex.org/W1988801692","https://openalex.org/W1995475257","https://openalex.org/W1996226077","https://openalex.org/W2002054377","https://openalex.org/W2005135448","https://openalex.org/W2014631569","https://openalex.org/W2016146312","https://openalex.org/W2023003085","https://openalex.org/W2023234757","https://openalex.org/W2025243241","https://openalex.org/W2025993954","https://openalex.org/W2030912789","https://openalex.org/W2036141586","https://openalex.org/W2037232977","https://openalex.org/W2038530296","https://openalex.org/W2044346387","https://openalex.org/W2046017312","https://openalex.org/W2046912474","https://openalex.org/W2047708866","https://openalex.org/W2053234614","https://openalex.org/W2059665153","https://openalex.org/W2061888378","https://openalex.org/W2065492264","https://openalex.org/W2072596428","https://openalex.org/W2074027399","https://openalex.org/W2074070805","https://openalex.org/W2076280319","https://openalex.org/W2093559498","https://openalex.org/W2094544071","https://openalex.org/W2095995901","https://openalex.org/W2096420012","https://openalex.org/W2096728414","https://openalex.org/W2099084891","https://openalex.org/W2100016308","https://openalex.org/W2102597208","https://openalex.org/W2103121999","https://openalex.org/W2105518878","https://openalex.org/W2106173052","https://openalex.org/W2112944917","https://openalex.org/W2116862105","https://openalex.org/W2127167047","https://openalex.org/W2127258982","https://openalex.org/W2127457915","https://openalex.org/W2145333208","https://openalex.org/W2145833822","https://openalex.org/W2148501195","https://openalex.org/W2152578678","https://openalex.org/W2168726045"],"related_works":["https://openalex.org/W2022382384","https://openalex.org/W2051612875","https://openalex.org/W2417636208","https://openalex.org/W2529231790","https://openalex.org/W1572696163","https://openalex.org/W1971540696","https://openalex.org/W2003946536","https://openalex.org/W2781705452","https://openalex.org/W2144278955","https://openalex.org/W2095995901"],"abstract_inverted_index":{"Glucagon":[0],"is":[1,36,46],"the":[2,8,56,79,94],"key":[3],"counter-regulatory":[4],"hormone":[5],"that":[6],"opposes":[7],"action":[9,116],"of":[10,14,41,62,69,81,96],"insulin.":[11,65],"In":[12,91],"states":[13],"relative":[15],"hypoglycaemia,":[16],"glucagon":[17,63,70,82,115],"acts":[18],"to":[19,30,52,113],"increase":[20],"blood":[21],"glucose":[22,43],"by":[23,38],"stimulating":[24],"hepatic":[25,42],"glycogen":[26],"breakdown":[27],"and":[28,64,73,100],"gluconeogenesis":[29],"achieve":[31],"euglycaemia.":[32],"Type":[33,121],"2":[34,122],"diabetes":[35],"characterised":[37],"inappropriate":[39],"regulation":[40],"production,":[44],"which":[45],"due,":[47],"at":[48],"least":[49],"in":[50,55],"part,":[51],"an":[53],"imbalance":[54],"bihormonal":[57],"relationship":[58],"between":[59],"plasma":[60],"levels":[61],"The":[66],"glucose-lowering":[67],"effects":[68],"peptide":[71],"antagonists":[72,105],"antiglucagon":[74],"neutralising":[75],"antibodies":[76],"first":[77],"demonstrated":[78],"potential":[80],"receptor":[83],"(GCGR)":[84],"antagonism":[85],"as":[86,109,117],"a":[87,118],"treatment":[88,119],"for":[89,120],"hyperglycaemia.":[90],"recent":[92],"years,":[93],"development":[95],"GCGR":[97,104],"antisense":[98],"oligonucleotides":[99],"small":[101],"molecular":[102],"weight":[103],"have":[106],"been":[107],"pursued":[108],"possible":[110],"therapeutic":[111],"agents":[112],"target":[114],"diabetes.":[123]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2053963792","counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
